Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness
Konstantin Tsoyi(University of Maryland, Baltimore), Iván O. Rosas(Brigham and Women's Hospital), Carmen S. Tellez, Souheil El‐Chemaly(AVEO Oncology (United States)), Sergio Poli(Brigham and Women's Hospital), Mark A. Perrella(Brigham and Women's Hospital), Juan C. Osorio(Laboratory of Molecular Genetics), Steven A. Belinsky(Lovelace Respiratory Research Institute), Lynette M. Sholl(Brigham and Women's Hospital), Sarah Chu(Brigham and Women's Hospital), Isis E. Fernandez(Ludwig-Maximilians-Universität München), Ye Cui(Capital Medical University), Jill M. Siegfried(University of Minnesota)
Cited by 30
Related Papers
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
|Nature Genetics|2018|701